Jonestrading assumed coverage on shares of Janux Therapeutics (NASDAQ:JANX – Free Report) in a research report released on Tuesday, Benzinga reports. The firm issued a buy rating and a $70.00 price objective on the stock. Other equities analysts also recently issued research reports about the company. Cantor Fitzgerald assumed coverage on Janux Therapeutics in a […]
Shares of Janux Therapeutics, Inc. (NASDAQ:JANX – Get Free Report) saw strong trading volume on Wednesday . 1,917,919 shares traded hands during mid-day trading, an increase of 181% from the previous session’s volume of 681,574 shares.The stock last traded at $45.49 and had previously closed at $40.03. Analyst Ratings Changes Several analysts have issued reports […]
Janux Therapeutics, Inc. (NASDAQ:JANX – Get Free Report) gapped up before the market opened on Monday . The stock had previously closed at $39.81, but opened at $41.98. Janux Therapeutics shares last traded at $40.58, with a volume of 45,945 shares. Wall Street Analyst Weigh In Several equities analysts have recently issued reports on the […]
Janux Therapeutics (NASDAQ:JANX – Get Free Report)‘s stock had its “outperform” rating reaffirmed by research analysts at Wedbush in a note issued to investors on Monday, RTT News reports. They currently have a $53.00 price target on the stock. Wedbush’s target price would indicate a potential upside of 32.60% from the company’s previous close. Other […]
Janux Therapeutics, Inc. (NASDAQ:JANX – Free Report) – Analysts at Wedbush issued their FY2028 earnings estimates for shares of Janux Therapeutics in a report issued on Tuesday, February 27th. Wedbush analyst R. Driscoll expects that the company will post earnings per share of ($1.45) for the year. Wedbush has a “Outperform” rating and a $53.00 […]